SCHEMBL13507846

SCHEMBL13507846

Cn1c2cc(-c3ccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)cc3)ccc2c2c3ccccc3c3c4ccc(-c5ccc(-c6c7ccccc7c(-c7ccc8ccccc8c7)c7ccccc67)cc5)cc4n(C)c3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 2/20 0.41
▸ MAOB P27338 1/20 0.41
▸ HTR1D P28221 1/20 0.38
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ IKBKB O14920 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ HSD11B1 P28845 2/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508164 0.96 LIMK1 (0.39) LIMK1MAOBHTR1DIKBKBHSD11B1
SCHEMBL13507906 0.95 LIMK1 (0.41) LIMK1MAOBHTR1DESR1ESR2
SCHEMBL13507850 0.93 LIMK1 (0.46) LIMK1MAOBHTR1DESR1ESR2
SCHEMBL13507734 0.92 LIMK1 (0.44) LIMK1MAOBHTR1DESR1ESR2
SCHEMBL13507633 0.91 MAOB (0.50) LIMK1MAOBHTR1DESR1ESR2
SCHEMBL13507085 0.88 RXRA (0.41) LIMK1MAOBHTR1DESR1ESR2
SCHEMBL13508060 0.88 MAOB (0.52) LIMK1MAOBRXRARXRBNPC1
SCHEMBL13507032 0.86 NQO2 (0.38) HTR1DESR1ESR2RXRARXRB
SCHEMBL13507629 0.86 LIMK1 (0.47) LIMK1MAOBESR1ESR2RXRA
SCHEMBL13506847 0.85 RXRA (0.38) LIMK1MAOBHTR1DESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 LIMK1 222/4885MAOB 446/4885HTR1D 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback